FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series C / Health care startups that raised Series C in North America

Health care startups that raised Series C in North America

Updated 16 Nov 2026

Reset
Health care startups that raised Series C in North America
One-time CSV
  • 634 funded companies, 594 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-c~north-america.csv634 rows × 18 columns
CompanyCityLast roundAmountDate
Delix TherapeuticsBostonSeries C$100.0M2026-11-09
GT Metabolic SolutionsSaint MichaelSeries C$17.1M2026-10-28
BigHat BiosciencesSan MateoSeries C$75.0M2026-09-24
ArchySan JoseSeries C$50.0M2026-09-11
PatientIQChicagoSeries C$30.0M2026-09-03
ImmunoPhotonicsSt LouisSeries C$10.1M2026-09-01
Channel MedsystemsBerkeleySeries C$30.0M2026-08-20
Bridge to LifeNorthbrookSeries C$110.0M2026-08-12

8 rows of the CSV in 5 of its 18 columns.

634
Startups
$60.5B
Total raised
59
Funded in the last 12 months
$3.7B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 634
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
GT Metabolic Solutions GT Metabolic Solutions develops an incision-less bypass technology for bariatric and metabolic surgery. Health care Saint Michael, United States Series C $17.1M 2026-10-28 $32.1M HealthTech Capital, Ceros Capital Markets 11 to 50 2021
BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo, United States Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019
Archy Archy provides dental practice management software that unifies patient care, communication, and reporting. Artificial intelligence San Jose, United States Series C $50.0M 2026-09-11 $93.0M Bessemer Venture Partners, CRV, Alven +2 101 to 250 2021
PatientIQ PatientIQ provides a healthcare data platform for collecting, analyzing, and integrating patient outcomes data. Artificial intelligence Chicago, United States Series C $30.0M 2026-09-03 $56.2M August Capital, Health Enterprise Partners 51 to 100 2016
ImmunoPhotonics ImmunoPhotonics is a biotechnology company that develops cancer immunotherapies to stimulate immune responses against tumors. Biotech St Louis, United States Series C $10.1M 2026-09-01 $42.0M TCA Venture Group, Cultivation Capital, Arch Grants +1 11 to 50 2012
Channel Medsystems Channel Medsystems manufactures cryotherapy devices for endometrial cryoablation procedures. Health care Berkeley, United States Series C $30.0M 2026-08-20 $97.9M Third Point Ventures, Green Park & Golf Ventures, Longwood Fund +1 11 to 50 2009
Bridge to Life Bridge to Life develops organ preservation and perfusion solutions for transplant centers and procurement organizations. Biotech Northbrook, United States Series C $110.0M 2026-08-12 $167.5M Perceptive Advisors 101 to 250 2005
Ratio Therapeutics Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. Biotech Boston, United States Series C $70.0M 2026-07-31 $160.0M Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments 11 to 50 2021
Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco, United States Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Polaris Partners, OrbiMed, Alexandria Venture Investments +2 11 to 50 2019
InStride Health InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. Health care Boston, United States Series C $30.0M 2026-06-15 $86.0M General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 251 to 500 2021
Stepful Stepful offers online training and certification programs for healthcare careers. Education New York, United States Series C $55.0M 2026-06-08 $111.0M Y Combinator, Unpopular Ventures, Reach Capital +2 11 to 50 2021
CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown, United States Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
Cerevance Cerevance develops novel therapeutics for neurological diseases. Biotech Boston, United States Series C $20.0M 2026-05-12 $209.5M Google Ventures, Casdin Capital, Foresite Capital +1 51 to 100 2016
Crown Affair Crown Affair sells haircare products and hair tools for daily maintenance, styling, and scalp care. Health care New York, United States Series C $5.0M 2026-05-07 $24.4M Alumni Ventures, Greycroft, Brand Foundry Ventures +2 11 to 50 2019
Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge, United States Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
Kashable Kashable provides employer-sponsored lending and financial wellness services to employees. Fintech New York, United States Series C $60.0M 2026-04-27 $472.6M Revolution, Alpaca VC, Moneta VC +2 101 to 250 2013
AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston, United States Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
Tava Health Tava Health is a digital mental health company that connects individuals with licensed therapists online. Health care Salt Lake City, United States Series C $40.0M 2026-04-21 $73.0M Pear VC, Kickstart, SaaS Ventures +2 101 to 250 2019
Summus Global Summus Global operates a virtual specialist platform that offers personalized medical advice. Health care New York, United States Series C $20.0M 2026-04-07 $84.3M Teamworthy Ventures, Outsiders Fund, Sator Grove Holdings +1 51 to 100 2015
Terrestrial Bio Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. Biotech Cambridge, United States Series C $50.0M 2026-03-26 $180.9M RA Capital Management, National Institutes of Health, The Engine 11 to 50 2012
Endogenex Endogenex develops an endoscopic procedure to help type 2 diabetes patients control blood glucose levels. Health care Plymouth, United States Series C $50.0M 2026-03-25 $163.0M Longitude Capital, Hatteras Venture Partners, Sante Ventures +1 11 to 50 2017
Adonis Adonis provides revenue cycle management software for healthcare organizations. Artificial intelligence New York, United States Series C $40.0M 2026-03-25 $93.9M General Catalyst, Point72 Ventures, Bling Capital +1 101 to 250 2022
Moxie Moxie provides software for managing MedSpa operations, including compliance, marketing, and patient management. Health care New York, United States Series C $25.0M 2026-03-10 $50.7M SignalFire, Boulton & Watt 101 to 250 2022
Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge, United States Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech San Francisco, United States Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
Colossal Biosciences Unicorn Colossal Biosciences uses gene editing technology to pursue de-extinction of species. Biotech Austin, United States Series C $60.0M 2026-02-03 $628.1M Boost VC, Capital Factory, Climate Capital 101 to 250 2021
Beacon Therapeutics Beacon Therapeutics develops treatments to preserve and restore vision for eye diseases. Biotech Alachua, United States Series C $75.0M 2026-01-08 $365.1M Oxford Science Enterprises, Forbion Capital Partners, Advent Life Sciences +1 101 to 250 2023
Codoxo Codoxo uses generative and self-learning AI to improve healthcare payment integrity. Artificial intelligence Duluth, United States Series C $35.0M 2025-12-17 $49.7M Service Provider Capital, QED Investors, Sands Capital Ventures +2 101 to 250 2017

Table 1. Health care startups that raised Series C in North America: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 634.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco, United States Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego, United States Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
3 Bridge to Life Bridge to Life develops organ preservation and perfusion solutions for transplant centers and procurement organizations. Biotech Northbrook, United States Series C $110.0M 2026-08-12 $167.5M Perceptive Advisors 101 to 250 2005
4 Cognito Therapeutics Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. Biotech Cambridge, United States Series C $105.0M 2026-03-05 $321.8M Morningside, FoundersX Ventures, IAG Capital Partners +1 11 to 50 2016
5 Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M Gaingels, RA Capital Management, Dolby Family Ventures +2 11 to 50 2019
6 Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech San Francisco, United States Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
7 CereVasc CereVasc develops a minimally invasive treatment for communicating hydrocephalus. Biotech Charlestown, United States Series C $85.0M 2026-06-04 $199.0M Perceptive Advisors, Bain Capital Life Sciences, ATON Partners 11 to 50 2014
8 AcuityMD AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. Artificial intelligence Boston, United States Series C $80.0M 2026-04-21 $163.0M Redpoint, Benchmark, ICONIQ Growth +2 251 to 500 2019
9 Iterative Health Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. Artificial intelligence Cambridge, United States Series C $77.0M 2026-04-30 $268.6M Plug and Play, Alumni Ventures, Insight Partners +1 251 to 500 2017
10 BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo, United States Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019

Table 2. Health care startups that raised Series C in North America: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 RA Capital Management Startup incubator Boston, United States 10 2% 2 Delix Therapeutics, Terrestrial Bio
2 Khosla Ventures Venture capital firm Menlo Park, United States 10 2% 2 Prellis Biologics, Loyal
3 Bristol-Myers Squibb Venture capital firm New York, United States 8 1% 2 BigHat Biosciences, Ratio Therapeutics
4 Y Combinator Startup accelerator Mountain View, United States 8 1% 1 Stepful
5 Alumni Ventures Angel group Manchester, United States 8 1% 2 Crown Affair, Iterative Health
6 Andreessen Horowitz Venture capital firm Menlo Park, United States 7 1% 1 BigHat Biosciences
7 General Catalyst Venture capital firm San Francisco, United States 7 1% 2 InStride Health, Adonis
8 Insight Partners Private equity firm New York, United States 7 1% 1 Iterative Health
9 National Science Foundation Entrepreneurship program Alexandria, United States 7 1%
10 Cormorant Asset Management Hedge fund Boston, United States 6 1% 2 Triveni Bio, Akura Medical
11 OrbiMed Private equity firm New York, United States 6 1% 2 Triveni Bio, Aspen Neuroscience
12 Google Ventures Corporate venture arm San Francisco, United States 6 1% 2 Cerevance, Aspen Neuroscience
13 Alexandria Venture Investments Venture capital firm Pasadena, United States 5 1% 2 Triveni Bio, Aspen Neuroscience
14 Invus Private equity firm New York, United States 5 1% 1 Triveni Bio
15 Polaris Partners Private equity firm Boston, United States 5 1% 1 Triveni Bio

Table 3. Health care startups that raised Series C in North America: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 320 50% $36.3B
Software 146 23% $16.3B
Artificial intelligence 61 10% $9.9B
Fintech 27 4% $3.2B
Hardware 23 4% $2.1B
Commerce 20 3% $623.0M
Education 7 1% $448.8M
Cybersecurity 4 1% $189.8M
Energy 4 1% $241.8M

Table 4. Health care startups that raised Series C in North America by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 634 100% $30.0M

Table 5. Health care startups that raised Series C in North America by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 620 98%
Canada 14 2%

Table 6. Health care startups that raised Series C in North America by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 54 9%
New York 40 6%
San Diego 31 5%
Boston 29 5%
Cambridge 26 4%
Menlo Park 17 3%
Austin 15 2%
Seattle 14 2%
Irvine 11 2%
Mountain View 11 2%
Palo Alto 10 2%
Los Angeles 9 1%

Table 7. Health care startups that raised Series C in North America by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 3% $115.0M
October 2026 3 5% $161.1M
September 2026 8 14% $514.1M
August 2026 3 5% $155.0M
July 2026 6 10% $601.0M
June 2026 7 12% $540.0M
May 2026 3 5% $25.0M
April 2026 7 12% $407.4M
March 2026 10 17% $422.0M
February 2026 3 5% $160.0M
January 2026 4 7% $395.0M
December 2025 2 3% $88.0M
November 2025 1 2% $115.0M

Table 8. Health care startups that raised Series C in North America: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 56 9% $3.5B
2025 59 9% $3.7B
2024 48 8% $3.3B
2023 37 6% $2.0B
2022 54 9% $3.2B
2021 61 10% $4.0B

Table 9. Health care startups that raised Series C in North America by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 7 1%
2020 to 2022 31 5%
2015 to 2019 201 32%
2010 to 2014 151 24%
Before 2010 240 38%

Table 10. Health care startups that raised Series C in North America by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 63 10%
11 to 50 245 39%
51 to 100 117 19%
101 to 250 127 20%
251 to 500 40 6%
501 to 1,000 26 4%
1,001 to 5,000 6 1%
5,001 to 10,000 1 0%
10,001 or more 4 1%

Table 11. Health care startups that raised Series C in North America by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in North America whose last round is Series C are on the list?
634, in the file dated 16 November 2026. 59 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 634 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series C in North America: 634 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in North America

Other sectors that raised Series C in North America

Cite: FundingWatcher, 634 health care companies in North America whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-c/north-america/